tm logo
HCI
Live/Registered
REGISTERED

on 02 May 2023

Last Applicant/ Owned by

2135 BEDELL ROAD, SUITE 9B

GRAND ISLAND

NY

14072

Serial Number

97169341 filed on 13th Dec 2021

Registration Number

7040282 registered on 02th May 2023

in the Principal Register

Correspondent Address

JOHN P. MURTAUGH

PEARNE & GORDON LLP

1801 EAST 9TH STREET, SUITE 1200

CLEVELAND OH 44114-3108

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

HCI

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases


First Use Date in General

31st Aug 2017

First Use Date in Commerce

31st Aug 2017

Class [042]
Computer & Software Services & Scientific Services


Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics


First Use Date in General

30th Jun 2017

First Use Date in Commerce

30th Jun 2017

Class [036]
Insurance & Financial Services


Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products


First Use Date in General

30th Jun 2017

First Use Date in Commerce

30th Jun 2017

Class [035]
Advertising, Business & Retail Services


Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations


First Use Date in General

30th Jun 2017

First Use Date in Commerce

30th Jun 2017

Specimens


HCI specimen

Mark Details


Serial Number

No 97169341

Mark Type

No Service Mark

Attorney Docket Number

No HYBR-65497

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th May 2023REGISTERED-PRINCIPAL REGISTER
02th May 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
14th Feb 2023PUBLISHED FOR OPPOSITION
14th Feb 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25th Jan 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Jan 2023APPROVED FOR PUB - PRINCIPAL REGISTER
28th Dec 2022TEAS/EMAIL CORRESPONDENCE ENTERED
27th Dec 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
27th Dec 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
17th Nov 2022NON-FINAL ACTION WRITTEN